The DOI matches its Crossref record; 10 of the 10 references it cites were found in a registry or an index.
Cumulative incidence of and predictive factors for lung cancer in IPF
Abstract
Background and objective: Previous studies have indicated a high incidence of lung cancer in IPF, and some have identified its risk factors. However, those studies were retrospective and the clinical characteristics of IPF patients developing lung cancer were evaluated only when those patients had developed the cancer. The true cumulative incidence of lung cancer after the diagnosis of IPF and its predictive factors at the initial diagnosis of IPF remain unknown. The present study was conducted to elucidate the cumulative incidence and risk factors for lung cancer in IPF patients by retrospective longitudinal cohort analysis. Methods: The study group consisted of 103 IPF patients without lung cancer at the time of their initial diagnosis. The cumulative incidence of lung cancer was estimated using the Kaplan–Meier method. The strength of association between several variables present at the initial diagnosis of IPF and the development of lung cancer was assessed using Cox proportional hazards regression analysis. Results: A total of 21 (20.4%) patients with IPF developed lung cancer during the observation period. The cumulative incidence rate of lung cancer increased as the duration of follow up increased (3.3%, 15.4% and 54.7% at 1, 5 and 10 years, respectively). Univariate Cox proportional hazards regression analysis showed that age and smoking at the initial diagnosis of IPF were significantly associated with lung cancer. Multivariate Cox proportional hazards regression analysis indicated that age at initial diagnosis was an independent significant factor predicting lung cancer. Conclusions: The cumulative incidence of lung cancer increased over time and age at diagnosis of IPF was independently associated with development of lung cancer.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
(2002) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.165.2.ats01 · Cited by 4,196
Combined pulmonary fibrosis and emphysema: a distinct underrecognised entity
Cottin, V., Nunes, H., Brillet, P.-Y., Delaval, P., Devouassoux, G., Tillie-Leblond, I., Israel-Biet, D., Court-Fortune, I., Valeyre, D., & Cordier, J.-F. (2005) · European Respiratory Journal · doi:10.1183/09031936.05.00021005 · Cited by 1,004
Predicting Survival in Idiopathic Pulmonary Fibrosis
KING, T. E., TOOZE, J. A., SCHWARZ, M. I., BROWN, K. R., & CHERNIACK, R. M. (2001) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.164.7.2003140 · Cited by 853
Lung Cancer and Cryptogenic Fibrosing Alveolitis: A Population-based Cohort Study
HUBBARD, R., VENN, A., LEWIS, S., & BRITTON, J. (2000) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.161.1.9906062 · Cited by 639
Association of Radiographic Emphysema and Airflow Obstruction with Lung Cancer
Wilson, D. O., Weissfeld, J. L., Balkan, A., Schragin, J. G., Fuhrman, C. R., Fisher, S. N., Wilson, J., Leader, J. K., Siegfried, J. M., Shapiro, S. D., et al. (2008) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200803-435oc · Cited by 489
Cryptogenic fibrosing alveolitis and lung cancer.
Turner-Warwick, M., Lebowitz, M., Burrows, B., & Johnson, A. (1980) · Thorax · doi:10.1136/thx.35.7.496 · Cited by 349
The incidence of cancer in patients with idiopathic pulmonary fibrosis and sarcoidosis in the UK
Le Jeune, I., Gribbin, J., West, J., Smith, C., Cullinan, P., & Hubbard, R. (2007) · Respiratory Medicine · doi:10.1016/j.rmed.2007.07.012 · Cited by 296
Cryptogenic fibrosing alveolitis with preserved lung volumes
Doherty, M. J., Pearson, M. G., O'Grady, E., Pellegrini, V., & Calverley, P. M. A. (1997) · Thorax · doi:10.1136/thx.52.11.998 · Cited by 134
Mortality rates from cryptogenic fibrosing alveolitis in seven countries.
Hubbard, R., Johnston, I., Coultas, D., & Britton, J. R. (1996) · Thorax · doi:10.1136/thx.51.7.711 · Cited by 108
Hironaka, M., & Fukayama, M. (1999) · Pathology International · doi:10.1046/j.1440-1827.1999.00989.x · Cited by 85
Cited by
Impact of Comorbidities on Mortality in Patients with Idiopathic Pulmonary Fibrosis
Kreuter, M., Ehlers-Tenenbaum, S., Palmowski, K., Bruhwyler, J., Oltmanns, U., Muley, T., Heussel, C. P., Warth, A., Kolb, M., & Herth, F. J. F. (2016) · PLOS ONE · doi:10.1371/journal.pone.0151425 · Cited by 351
Idiopathic Pulmonary Fibrosis and Lung Cancer: Mechanisms and Molecular Targets
Ballester, B., Milara, J., & Cortijo, J. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20030593 · Cited by 308
Galati, D., De Martino, M., Trotta, A., Rea, G., Bruzzese, D., Cicchitto, G., Stanziola, A. A., Napolitano, M., Sanduzzi, A., & Bocchino, M. (2014) · Cytokine · doi:10.1016/j.cyto.2013.12.003 · Cited by 95
Akaike, K., Saruwatari, K., Oda, S., Shiraishi, S., Takahashi, H., Hamada, S., Iyama, S., Horio, Y., Tomita, Y., Saeki, S., et al. (2020) · International Journal of Clinical Oncology · doi:10.1007/s10147-019-01584-x · Cited by 23
Kikuchi, R., Takoi, H., Tsuji, T., Nagatomo, Y., Tanaka, A., Kinoshita, H., Ono, M., Ishiwari, M., Toriyama, K., Kono, Y., et al. (2021) · Thoracic Cancer · doi:10.1111/1759-7714.13792 · Cited by 15
Metadata
- Authors
- OZAWA, Y., SUDA, T., NAITO, T., ENOMOTO, N., HASHIMOTO, D., FUJISAWA, T., NAKAMURA, Y., INUI, N., NAKAMURA, H., & CHIDA, K.
- Venue
- Respirology
- Publisher
- Wiley
- Published
- 2009-07
- Volume
- 14
- Issue
- 5
- Pages
- 723-728
- ISSN
- 1323-7799 (ISSN-L)
- 1440-1843
- OpenAlex
- W2009183164
- Cited by
- 314
- References
- 10
- FWCI
- 4.32
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Cumulative incidence of and predictive factors for lung cancer in IPF. https://app.cochat.ai/papers/10.1111/j.1440-1843.2009.01547.x
- The paper
- OZAWA, Y., SUDA, T., NAITO, T., ENOMOTO, N., HASHIMOTO, D., FUJISAWA, T., NAKAMURA, Y., INUI, N., NAKAMURA, H., & CHIDA, K. (2009). Cumulative incidence of and predictive factors for lung cancer in IPF. Respirology. https://doi.org/10.1111/j.1440-1843.2009.01547.x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.
